BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16330379)

  • 1. [Contribution of proteomic analysis to study cardiovascular physiopathology].
    Dupont A; Pinet F
    Ann Biol Clin (Paris); 2005; 63(6):611-7. PubMed ID: 16330379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteomics in cardiology].
    Pinet F
    Arch Mal Coeur Vaiss; 2007 Jan; 100(1):47-51. PubMed ID: 17405554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis in cardiovascular diseases.
    Cieniewski-Bernard C; Acosta A; Dubois E; Lamblin N; Beseme O; Chwastyniak M; Amouyel P; Bauters C; Pinet F
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):362-6. PubMed ID: 18307721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular proteomic analysis.
    Suzuki T; Nagai R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):28-34. PubMed ID: 17350900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic approaches for identifying new allergens and diagnosing allergic diseases.
    González-Buitrago JM; Ferreira L; Isidoro-García M; Sanz C; Lorente F; Dávila I
    Clin Chim Acta; 2007 Oct; 385(1-2):21-7. PubMed ID: 17707361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research.
    You SA; Wang QK
    Methods Mol Med; 2006; 129():15-26. PubMed ID: 17085802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of proteomics in cardiovascular medicine.
    Lam L; Lind J; Semsarian C
    Int J Cardiol; 2006 Mar; 108(1):12-9. PubMed ID: 16466817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteomics and the kidney: an innovative approach to the study of renal disease].
    Netti GS; Rocchetti MT; Papale M; Centra M; Centonze D; Di Paolo S; Ranieri E; Gesualdo L
    G Ital Nefrol; 2008; 25(2):169-82. PubMed ID: 18350497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C
    Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics: the next revolution in laboratory medicine?
    Plebani M
    Clin Chim Acta; 2005 Jul; 357(2):113-22. PubMed ID: 15941565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics makes progress in cartilage and arthritis research.
    Wilson R; Whitelock JM; Bateman JF
    Matrix Biol; 2009 Apr; 28(3):121-8. PubMed ID: 19379666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of bronchoalveolar lavage fluid.
    Wattiez R; Falmagne P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):169-78. PubMed ID: 15652807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics technology and therapeutics.
    Hong ML; Jiang N; Gopinath S; Chew FT
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):563-8. PubMed ID: 16700895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HepatoProteomics: applying proteomic technologies to the study of liver function and disease.
    Diamond DL; Proll SC; Jacobs JM; Chan EY; Camp DG; Smith RD; Katze MG
    Hepatology; 2006 Aug; 44(2):299-308. PubMed ID: 16871559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.
    López-Pedrera C; Barbarroja N; Aguirre MA; Torres LA; Velasco F; Cuadrado MJ
    Lupus; 2008 Oct; 17(10):904-15. PubMed ID: 18827055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteomic analysis of cancer cells].
    Tomancová A; Sedo O; Zdráhal Z; Mayer J; Pospísilová S
    Klin Onkol; 2009; 22(5):210-7. PubMed ID: 19886358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress of proteomics in critical illness.
    Karvunidis T; Mares J; Thongboonkerd V; Matejovic M
    Shock; 2009 Jun; 31(6):545-52. PubMed ID: 19106823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.